New pill shows promise for tough bladder cancer cases
Disease control
Not yet recruiting
This study tests an experimental daily pill called zanzalintinib in 44 adults with advanced bladder cancer that has continued to grow after previous treatments. The goal is to see if the drug can shrink tumors or slow the cancer's progression. Participants will take the pill once…
Phase: PHASE2 • Sponsor: Guru Sonpavde • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC